Novo Nordisk A/S (ETR:NOV)
Germany · Delayed Price · Currency is EUR 41.85
+0.49 (1.17%)
Aug 1, 2025, 10:49 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of €183.53 billion as of August 1, 2025. Its market cap has decreased by -68.17% in one year.
Market Cap
183.53B
Enterprise Value
193.86B
Revenue
40.64B
Ranking
n/a
PE Ratio
13.09
Stock Price
€41.85
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 6.23B to 183.53B, an increase of 2,847.46%. That is a compound annual growth rate of 12.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 183.53B | -50.64% |
| Dec 30, 2024 | 371.85B | -10.95% |
| Dec 29, 2023 | 417.56B | 46.59% |
| Dec 30, 2022 | 284.85B | 26.44% |
| Dec 30, 2021 | 225.29B | 69.93% |
| Dec 30, 2020 | 132.58B | 8.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.71B |
| Merck KGaA | 47.96B |
| Bayer Aktiengesellschaft | 26.87B |
| Fresenius SE & Co. KGaA | 23.64B |
| Fresenius Medical Care AG | 13.05B |
| Sartorius Aktiengesellschaft | 11.85B |
| Fielmann Group AG | 4.67B |
| Carl Zeiss Meditec AG | 4.26B |